Get 3 shares of TTNP for 1 share of FOLD and never look back.
TTTNP has a 6 month slow release abuse proof medication.
Its ProNeura technology is also being advanced for Parkinson's and chronic pain.
Almost certain approval will fetch a $50M milestone.
Probuphine is an off patent drug being utilized with Titan's delivery technology.
The growing US market was $1.3 billion last year and Titan's superior technology will compete with RB's abusive drug. RB is the only company in the field.